Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung

Pathology Research and Practice

Volumn 209, Issue 9, 2013, Pages 578-584

  Mireskandari, Masoud ^a   Abdirad, Azita ^a   Zhang, Qing ^a   Dietel, Manfred ^b   Petersen, Iver ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adenocarcinoma of lung; Diffuse idiopathic pulmonary neueroendocrine cell hyperplasia (DIPNECH); Grading of lung adenocarcinoma; Lung preneoplasia

Indexed keywords

SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CASE REPORT; CELL HYPERPLASIA; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; NEUROSECRETORY CELL; PRECANCER; SURVIVAL TIME;

ADENOCARCINOMA OF LUNG; DIFFUSE IDIOPATHIC PULMONARY NEUEROENDOCRINE CELL HYPERPLASIA (DIPNECH); GRADING OF LUNG ADENOCARCINOMA; LUNG PRENEOPLASIA;

ADENOCARCINOMA; AGED; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE CELLS; PRECANCEROUS CONDITIONS;

EID: 84883554763     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.06.019     Document Type: Article

References (22)

1. Gosney J.r., Travis W.D. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Tumors of the Lung, Pleura, Thymus and Heart 2004, 76-77. IARC Press.
2. Warth A., Herpel E., Schmähl A., Storz K., Schnabel P.A. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report. J. Med. Case Rep. 2008, 2(January):21.
3. Gosney J.R., Williams I.J., Dodson A.R., Foster C.S. Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology 2011, 59:751-762.
4. Falkenstern R.F., Kimmich M., Friedel G., Tannapfel A., Neumann V., Kohlhaeufl M.M. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome. J. Cancer Res. Clin. Oncol. 2011, 137:1495-1498.
5. Stenzinger A., Weichert W., Hensel M., Bruns H., Dietel M., Erbersdobler A. Incidental postmortem diagnosis of Dipnech in a patient with previously unexplained asthma bronchiale. Pathol. Res. Pract. 2010, 206(November (11)):785-787.
6. Cameron C.M., Roberts F., Connel J., Sproule M.W. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an unusual cause of cyclical ectopic adrenocorticotrophic syndrome. Br. J. Radiol. 2011, 84(January (997)):e14-e17. 10.1259/bjr/91375895.
7. Ruffini E., Bongiovanni M., Cavallo A., Filosso P.I., Giobbe R., Mancuso M., Molinatti M., Oliaro A. The significance of associated pre-invasive lesions in the patients resected for primary lung neoplasms. Eur. J. Cardiothorac. Surg. 2004, 26(July (1)):165-172.
8. Irshad S., McLean E., Rankin S., Barrington S., Santis G., Spicer J., Lang-Lazdunski L. Unilateral diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and multiple carcinoids treated with surgical resection. J. Thorac. Oncol. 2010, 5(June (6)):921-923.
9. Lantuejoul S., Salameire D., Salon C., Brambilla E. Pulmonary preneoplasia - sequential molecular carcinogenetic events. Histopathology 2009, 54:43-54.
10. Bubendorf L. Preneoplastic lesions of pulmonary carcinoma. Pathologe 2011, 32(November (Suppl. 2)):218-223. (article in German).
11. Wistuba I.I., Gazdar A.F. Lung cancer preneoplasia. Annu. Rev. Pathol. Mech. Dis. 2006, 1:331-348.
12. Gorshtein A., Gross D.J., Barak D., Sternov Y., Rafaeli Y., Shimon I., Grozinsky-Glasberg S. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors. Cancer 2012, 118(February (3)):612-619. 10.1002/cncr.26200.
13. Travis W.D., Brambilla E., Noguchi M., Nicholson A., et al. International Association for Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidiciplinary Classification of Lung Adenocarcinoma. J. Thorac. Oncol. 2011, 6(February (2)):244-285.
14. Yoshizawa A., Motoi N., Riely G.J., et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod. Pathol. 2011, 24:653-664.
15. Russell P.A., Wainer Z., Wright G.M., et al. Does lung adenocarcinoma subtype predict survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification. J. Thorac. Oncol. 2011, 9:1496-1504.
16. Warth A., Muley T., Meister M., et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J. Clin. Oncol. 2012, 30:1438-1446.
17. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(November (24)):13784-13789. (Erratum in: Proc Natl Acad Sci U S A 99 (January (2)) (2002) 1098).
18. Petersen I., Kotb W.F., Friedrich K.H., Schlüns K., Böcking A., Dietel M. Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 2009, 65(September (3)):312-318.
19. Nakazato Y., Minami Y., Kobayashi H., Satomi K., Anami Y., Tsuta K., Tanaka R., Okada M., Goya T., Noguchi M. Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer 2010, 116(April (8)):2011-2019.
20. Rizvi S.M., Goodwill J., Lim E., Yap Y.K., Wells A.U., Hansell D.M., Davis P., Selim A.G., Goldstraw P., Nicholson A.G. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas. Histopathology 2009, 55(September (3)):332-337.
21. Petersen I., Petersen S. Towards a genetic-based classification of human lung cancer. Anal. Cell. Pathol. 2001, 22(3):111-121.
22. Petersen I., Schnabel P. What's new in lung pathology: minutes from the Pulmonary Pathology Working Group of the German Society of Pathology. Pathologe 2011, (Suppl. 2):351-357. (article in German).